PAUL RACKHAM LIMITED

Company number 02434505 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: PAUL RACKHAM LIMITED

1. Financial Health Score: B+

Explanation: This is a fundamentally robust, asset-rich company with a strong equity base and consistent growth in net assets over many years. However, the score is held back from a higher grade due to a technical liquidity concern — a large inter-company loan reclassification that creates the appearance of net current liabilities. Underneath this accounting presentation, the underlying business health is sound, with substantial property assets, growing retained earnings, and improving cash reserves.


2. Key Vital Signs

Vital Sign 2024 2023 Interpretation
Net Assets £38,746,519 £37,911,466 Healthy — Growing steadily year-on-year
Net Asset Growth +£835,053 (+2.2%) +£947,233 (+2.6%) Stable — Growth continuing but slowing
Total Assets £61,690,632 £60,971,269 Strong — Substantial asset base
Cash £1,821,036 £1,168,616 Improving — 56% increase year-on-year
Retained Earnings £25,396,644 £24,561,591 Healthy — Consistent profit retention
Net Current Liabilities (£15,780,425) £2,349,904 Distorted — Inter-company loan reclassification
Gearing (Liabilities/Net Assets) 53.6% 50.4% Moderate — Acceptable for property-heavy business
Shareholders' Funds £38,746,519 £37,911,466 Strong — Well-capitalised

Long-Term Growth Trajectory

The company has demonstrated remarkable long-term value creation:

Year Net Assets Growth
2015 £19,606,665 —
2018 £20,344,465 +3.8%
2020 £34,775,489 +70.9%*
2022 £36,964,233 +6.3%
2024 £38,746,519 +4.8%

*The significant jump in 2020 reflects property revaluations, which is typical for farming and real estate operations.


3. Diagnosis

What the Financial Data Reveals About Business Health

The Patient is Fundamentally Healthy, But With a Notable Irregularity

Think of this company as a patient with a strong constitution and excellent bone density (substantial property assets), good cardiovascular fitness (positive cash flow generation), and a steady weight gain pattern (growing net assets). However, there's an irregular reading on one diagnostic test that requires interpretation.

The Inter-Company Loan "Symptom"

The most striking feature of the 2024 balance sheet is the net current liabilities position of (£15,780,425) — a dramatic swing from net current assets of £2,349,904 in 2023. At first glance, this looks like a patient in acute distress.

However, examining the underlying cause reveals this is not a genuine liquidity crisis. The company has reclassified a loan due to a subsidiary from long-term to current liabilities:

  • 2023: Creditors due within one year: £1,783,838; Creditors due after one year: £19,116,820
  • 2024: Creditors due within one year: £20,769,467; Creditors due after one year: £0

The directors explicitly note in the accounts that this loan "has no fixed repayment terms, and as such, is repayable upon demand. However, the directors have indicated that no demands for repayment will be made until such time that the company has sufficient funds to meet the liability."

This is analogous to a family member lending you money and saying "pay me back whenever you can" — technically it could be demanded tomorrow, but in practice it won't be. The subsidiary (likely within the Rackham Group) has no intention of calling this loan.

Asset Composition — The Property Backbone

The company's asset base is heavily concentrated in property:

Asset Category 2024 Value % of Total Assets
Tangible Fixed Assets (land, buildings, plant) £44,670,610 72.4%
Investment Property £6,727,551 10.9%
Investments (subsidiaries) £5,303,429 8.6%
Current Assets (debtors, cash, stock) £4,989,042 8.1%
Total £61,690,632 100%

This is a property-rich, illiquid balance sheet — typical for farming and real estate operations. The fair value reserve of £10,898,078 indicates significant property revaluation gains have been recognised over the years.

Cash Flow Health — Improving

The cash position has strengthened considerably: - 2022: £902,380 - 2023: £1,168,616 - 2024: £1,821,036

This represents a 102% increase over two years, suggesting the underlying trading operations are generating healthy cash flows. This is a positive vital sign — the business is not bleeding cash despite the apparent current liabilities position.

Equity Strength — Robust

The capital structure is conservatively funded:

Equity Component 2024 Value % of Shareholders' Funds
Called-up Share Capital £113,776 0.3%
Share Premium £2,338,021 6.0%
Fair Value Reserve £10,898,078 28.1%
Retained Earnings £25,396,644 65.6%
Total £38,746,519 100%

Over 65% of equity is represented by retained earnings — profits that have been reinvested in the business rather than distributed. This demonstrates disciplined capital allocation and long-term wealth building.

Areas of Concern

  1. Slowing Growth: Net asset growth has decelerated from 4.2% (2021-22) to 2.2% (2023-24). This may reflect maturing operations, softer property values, or reduced trading profitability.

  2. Property Value Dependency: With 83% of assets in property-related categories, the company's financial health is heavily tied to agricultural and rural property values. A downturn in this market would directly impact net assets.

  3. Inter-Company Dependency: The £20.77M current liability creates a technical dependency on the subsidiary's forbearance. While practically manageable, it could create complications in insolvency scenarios or if group relationships change.

  4. Limited Diversification: The SIC codes (mixed farming and real estate) suggest concentration in related rural sectors, making the company vulnerable to agricultural policy changes, commodity price fluctuations, or rural market downturns.


4. Recommendations

Immediate Actions

  1. Restructure the Inter-Company Loan: Negotiate formal repayment terms with the subsidiary that align with the company's actual cash generation capacity. Even a 10-year repayment schedule with annual reviews would remove the technical going concern uncertainty and present a clearer picture of financial health to any external stakeholders.

  2. Cash Flow Forecasting: Develop detailed cash flow projections for the next 12-24 months to ensure the improving cash position is sustainable and not dependent on one-off events.

Medium-Term Strategies

  1. Diversification Assessment: Evaluate whether the concentration in farming and rural property represents an acceptable risk profile, or whether diversification into complementary business lines would strengthen resilience.

  2. Property Portfolio Review: With over £51M in property assets, commission independent valuations to ensure the carrying values remain appropriate, particularly given current market uncertainties in the agricultural sector following policy changes.

  3. Growth Strategy: The slowing net asset growth suggests the business may be reaching maturity. Consider whether strategic reinvestment (new acquisitions, development projects) or selective diversification could reinvigorate growth rates.

Ongoing Monitoring

  1. Quarterly Health Checks: Monitor the following vital signs quarterly: - Cash position and trends - Inter-company loan status and any reclassification - Property valuations in the local market - Retained earnings growth rate - Working capital position (excluding inter-company items)

  2. Succession Planning: With director name shown to subscribers having resigned in May 2026, ensure governance continuity and that the remaining board has appropriate capacity and expertise.


Summary Assessment

Assessment Area Rating Comment
Asset Strength A Substantial, growing property portfolio
Equity Position A Strong retained earnings, well-capitalised
Liquidity (Adjusted) B Healthy once inter-company distortion is recognised
Liquidity (Reported) D Net current liabilities due to loan reclassification
Growth Trajectory B Positive but slowing
Cash Generation B+ Improving trend
Risk Profile B Concentrated in property/agriculture
Overall B+ Fundamentally sound with technical irregularity

Names of the people mentioned are shown to subscribers. See subscription

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 18 September 2026